Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Evonik plans to build production plant in Slovakia

Published 14/01/2022, 08:54
Updated 14/01/2022, 09:22
© Reuters. FILE PHOTO: The logo of German specialty chemical company Evonik Industries AG is pictured at their plant in Bitterfeld, Germany, February 29, 2016. REUTERS/Fabrizio Bensch

(Reuters) -German chemicals group Evonik Industries on Friday said it planned to build a production plant in Slovakia for rhamnolipids, which are used in many consumer goods including cosmetics.

Evonik said it would spend an amount in the "low three-digit million euros" but gave no further details on the actual sum to be invested. It said the new plant would strengthen its partnership with consumer goods group Unilever (LON:ULVR).

Rhamnolipids, which are fully biodegradable substances produced by bacteria by fermentation of sugar, are not oil-based and allow the manufacture of environmentally friendly products including detergents and cleaning agents.

"The journey of rhamnolipids from the initial idea to the finished product has been long, but it is worth it. This partnership with Unilever is a result of our expertise in biotechnology," Chief Innovation Officer Harald Schwager said.

The new plant is expected to be operational in two years, Evonik added.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.